secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001558370-24-006460
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IRADIMED reports record Q1 revenue of $17.6M, up 13.7% YoY; EPS $0.32 GAAP, $0.36 non-GAAP
--------------------------------------------------------------------------------

- Q1 2024 record revenue $17.6M, +13.7% YoY; operating income $4.7M, +18.5%.
- GAAP diluted EPS $0.32, non-GAAP $0.36; net income $4.1M, +21.4%.
- Declared regular quarterly dividend of $0.15/share payable May 30, 2024 to holders of record May 20.
- Q2 2024 guidance: revenue $17.6-17.8M, GAAP EPS $0.33-0.36, non-GAAP $0.36-0.39.
- FY 2024 guidance reiterated: revenue $72-74M, GAAP EPS $1.37-1.47, non-GAAP $1.52-1.62.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000155837024006460/0001558370-24-006460-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000155837024006460/irmd-20240502x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-006460

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer